Ingevity (NYSE:NGVT) reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Materials business and continued share repurchases.
On the company’s earnings call, President and CEO
NiSource (NYSE:NI) reaffirmed its 2026 earnings outlook and raised its long-term growth expectations after reporting first-quarter adjusted earnings that management said reflected regulatory execution, infrastructure investment recovery and growing momentum in its data center strategy.
The regulate
Nomad Foods (NYSE:NOMD) reported first-quarter 2026 results that management said were slightly ahead of internal expectations, despite lower organic revenue, margin pressure and a sharp year-over-year decline in adjusted EBITDA.
Chief Executive Officer Dominic Brisby, speaking on his second quarter
Beta Bionics (NASDAQ:BBNX) Chief Financial Officer Stephen Feider said the company’s first-quarter outperformance was supported by increasing use of the pharmacy reimbursement channel, expanded sales coverage and growing confidence in the company’s iLet insulin pump platform.
Speaking at a Bank of
Natural Grocers by Vitamin Cottage (NYSE:NGVC) reported modest sales growth and higher earnings for its fiscal second quarter, as management said disciplined expense controls and store execution helped offset a more cautious consumer environment.
On the company’s earnings call, Chairman and Co-Pres
